基于外泌体miRNA-221调控PI3K/Akt/Ca2+轴探讨针刺治疗荨麻疹的效应机制
批准号:
82105026
项目类别:
青年科学基金项目(C类)
资助金额:
30.0 万元
负责人:
石云舟
依托单位:
学科分类:
中医针灸学
结题年份:
2024
批准年份:
2021
项目状态:
已结题
项目参与者:
石云舟
中文摘要
荨麻疹是常见的皮肤病,治疗难度大,症状反复发作,严重影响患者生活质量。我们前期研究已证实针刺治疗该病疗效确切,但其效应机制尚待深入研究。既往研究明确肥大细胞是荨麻疹的关键效应细胞,miRNA-221通过PI3K/Akt/Ca2+轴抑制肥大细胞脱颗粒而发挥调节效应。最新研究表明外泌体作为细胞通讯的重要载体,可传递活性分子与免疫球蛋白E结合来抑制变态反应。有研究提出外泌体在针刺信息传递中扮演重要角色,且已证实针刺通过影响外泌体miRNA的表达而发挥治疗作用。据此,本课题围绕“针刺通过调节外泌体miRNA-221以介导PI3K/Akt/Ca2+轴抑制肥大细胞脱颗粒而改善荨麻疹症状”的研究假说,以荨麻疹模型大鼠为研究对象,以外泌体miRNA-221为切入点,从肥大细胞入手,通过甲苯胺蓝染色、透射电镜、流式细胞仪、Western Blot、RT-PCR等方法深入阐释针刺治疗荨麻疹的效应机制。
英文摘要
Urticaria is a common disease in the field of skin allergies. Because of its difficulty in treatment and recurring symptoms, it seriously affects the quality of life of patients. It is a hot spot in clinical research. Our previous studies have confirmed that acupuncture has a definite effect, but its mechanism needs to be further deepened. Mast cell is the key effector cell in allergic diseases such as urticaria. Existing studies have shown that miRNA regulates the biological process of mast cell, and miRNA-221 can inhibit mast cell degranulation through the PI3K/Akt/Ca2+ signaling pathway. The latest research shows that exosomes and their cargoes are important carriers for the communication between nerves, endocrine, immune and other cells, and can transmit active molecules to bind with immunoglobulin E to inhibit allergic reactions. Related research suggests that exosomes may play an important role in acupuncture information transmission, and it has been confirmed that acupuncture can play a role by affecting the expression level of exosomal miRNA. Therefore, we hypothesis that acupuncture can improve urticaria symptoms by regulating exosomal miRNA-221-mediated PI3K/Akt/Ca2+ axis to inhibit mast cell degranulation.We plan to use urticaria model rats as the research subjects, take exosomal miRNA-221 and mast cell degranulation as an entry point, and use toluidine blue staining, transmission electron microscopy, flow cytometry, Western Blot, RT-PCR and other methods to explain the effect mechanism of acupuncture in the treatment of urticaria.
荨麻疹是临床常见病、多发病。严重影响患者生活质量,是临床和研究的热点,团队前期已证实针灸治疗荨麻疹临床疗效确切。外泌体作为细胞间通讯的重要载体,能够将内部包裹的蛋白、miRNA和ncRNAs等多种物质分子递送至靶细胞,实现在细胞间的信息传递。相关研究提出外泌体参与针灸信息传递,并已证实针灸可调节外泌体miRNA的表达水平而产生治疗作用。.本研究以外泌体miRNA为切入点,从肥大细胞脱颗粒这一关键效应细胞活化入手,以外泌体miRNA为切入点,采取动物实验-细胞实验相互结合、相互验证的方式,去揭示针刺通过调节外泌体miRNA探究下游信号通路对荨麻疹症状改善的分子机制。q-PCR验证发现,目标miRNA-221与原本假说存在差异,因此,采用高通量测序的方法重新对三组血浆外泌体中的miRNA进行筛选,基于测序数据结合国内外研究,确定miRNA-451-5p可能是更有意义的靶点,基于此,重新调整实验方案。. 结果表明:1.电针可提升血浆外泌体miRNA-451-5p的表达,从而改善荨麻疹大鼠瘙痒行为,降低肥大细胞脱颗粒率,达到抑制荨麻疹大鼠的过敏反应的效果。2.ACU-exo可通过传递miRNA-451-5p,减少TLR4蛋白表达,进而抑制p38MAPK、p-ERK蛋白磷酸化,减少炎性因子TNF-α、IL-6释放,进而减少RBL-2H3类肥大细胞模型脱颗粒,抑制过敏反应。3.ACU-exo中携带miRNA-451-5p,回输后具有类针刺的作用,通过抑制TLR4/MAPKs信号通路减少炎性因子释放,降低肥大细胞脱颗粒,进而缓解荨麻疹大鼠的过敏反应。
针刺调控S100A4乳酸化修饰介导线粒体—钙稳态“平衡重构”治疗慢性荨麻疹的效应机制研究
-
批准号:82575218
-
项目类别:面上项目
-
资助金额:51.00万元
-
批准年份:2025
-
负责人:石云舟
-
依托单位:
国内基金
海外基金